These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17118960)

  • 1. Azaspiracid-1 alters the E-cadherin pool in epithelial cells.
    Ronzitti G; Hess P; Rehmann N; Rossini GP
    Toxicol Sci; 2007 Feb; 95(2):427-35. PubMed ID: 17118960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective disruption of the E-cadherin-catenin system by an algal toxin.
    Ronzitti G; Callegari F; Malaguti C; Rossini GP
    Br J Cancer; 2004 Mar; 90(5):1100-7. PubMed ID: 14997213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azaspiracid-1 inhibits endocytosis of plasma membrane proteins in epithelial cells.
    Bellocci M; Sala GL; Callegari F; Rossini GP
    Toxicol Sci; 2010 Sep; 117(1):109-21. PubMed ID: 20547569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of yessotoxin stabilizes E-cadherin in mouse colon.
    Callegari F; Sosa S; Ferrari S; Soranzo MR; Pierotti S; Yasumoto T; Tubaro A; Rossini GP
    Toxicology; 2006 Oct; 227(1-2):145-55. PubMed ID: 16950554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yessotoxin inhibits the complete degradation of E-cadherin.
    Callegari F; Rossini GP
    Toxicology; 2008 Feb; 244(2-3):133-44. PubMed ID: 18155346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azaspiracid-1 inhibits the maturation of cathepsin D in mammalian cells.
    Sala GL; Bellocci M; Callegari F; Rossini GP
    Chem Res Toxicol; 2013 Mar; 26(3):444-55. PubMed ID: 23387425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Effects of Lipophilic Phycotoxins (Okadaic Acid, Azapsiracid-1 and Yessotoxin) on Human Intestinal Cells Models.
    Ferron PJ; Dumazeau K; Beaulieu JF; Le Hégarat L; Fessard V
    Toxins (Basel); 2016 Feb; 8(2):50. PubMed ID: 26907345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report on azaspiracid and yessotoxin groups detection in French shellfish.
    Amzil Z; Sibat M; Royer F; Savar V
    Toxicon; 2008 Jul; 52(1):39-48. PubMed ID: 18573273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cardiomyocyte response to YTX- and AZA-1-induced damage: autophagy versus apoptosis.
    Ferreiro SF; Vilariño N; Carrera C; Louzao MC; Santamarina G; Cantalapiedra AG; Cifuentes JM; Crespo A; Botana LM
    Arch Toxicol; 2017 Apr; 91(4):1859-1870. PubMed ID: 27709272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible cytoskeletal disarrangement is independent of caspase activation during in vitro azaspiracid toxicity in human neuroblastoma cells.
    Vilariño N; Nicolaou KC; Frederick MO; Vieytes MR; Botana LM
    Biochem Pharmacol; 2007 Jul; 74(2):327-35. PubMed ID: 17485074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yessotoxin induces the accumulation of altered E-cadherin dimers that are not part of adhesive structures in intact cells.
    Ronzitti G; Rossini GP
    Toxicology; 2008 Feb; 244(2-3):145-56. PubMed ID: 18155345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine toxins and the cytoskeleton: azaspiracids.
    Vilariño N
    FEBS J; 2008 Dec; 275(24):6075-81. PubMed ID: 19016861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell growth inhibition and actin cytoskeleton disorganization induced by azaspiracid-1 structure-activity studies.
    Vilariño N; Nicolaou KC; Frederick MO; Cagide E; Ares IR; Louzao MC; Vieytes MR; Botana LM
    Chem Res Toxicol; 2006 Nov; 19(11):1459-66. PubMed ID: 17112233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of yessotoxins in cultured cells.
    Ferrari S; Ciminiello P; Dell'Aversano C; Forino M; Malaguti C; Tubaro A; Poletti R; Yasumoto T; Fattorusso E; Rossini GP
    Chem Res Toxicol; 2004 Sep; 17(9):1251-7. PubMed ID: 15377159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and cytoskeletal effects of azaspiracid-1 on mammalian cell lines.
    Twiner MJ; Hess P; Dechraoui MY; McMahon T; Samons MS; Satake M; Yasumoto T; Ramsdell JS; Doucette GJ
    Toxicon; 2005 Jun; 45(7):891-900. PubMed ID: 15904684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic effects of azaspiracid-1 identified by microinjection of Japanese medaka (Oryzias latipes) embryos.
    Colman JR; Twiner MJ; Hess P; McMahon T; Satake M; Yasumoto T; Doucette GJ; Ramsdell JS
    Toxicon; 2005 Jun; 45(7):881-90. PubMed ID: 15904683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of the marine algal toxins azaspiracid-1, -2, and -3 on Jurkat T lymphocyte cells.
    Twiner MJ; El-Ladki R; Kilcoyne J; Doucette GJ
    Chem Res Toxicol; 2012 Mar; 25(3):747-54. PubMed ID: 22375692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional assay to measure yessotoxins in contaminated mussel samples.
    Pierotti S; Malaguti C; Milandri A; Poletti R; Paolo Rossini G
    Anal Biochem; 2003 Jan; 312(2):208-16. PubMed ID: 12531207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined oral toxicity of azaspiracid-1 and yessotoxin in female NMRI mice.
    Aasen JA; Espenes A; Miles CO; Samdal IA; Hess P; Aune T
    Toxicon; 2011 May; 57(6):909-17. PubMed ID: 21426911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azaspiracid substituent at C1 is relevant to in vitro toxicity.
    Vilariño N; Nicolaou KC; Frederick MO; Cagide E; Alfonso C; Alonso E; Vieytes MR; Botana LM
    Chem Res Toxicol; 2008 Sep; 21(9):1823-31. PubMed ID: 18707138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.